Neuropeptide Y: The story, the players, the outcomes

Nerve-Driven Immunity: Neurotransmitters and Neuropeptides in the Immune System

Volumn , Issue , 2012, Pages 227-256

  Dimitrijević, Mirjana ^a   Stanojević, Stanislava ^a  

^a Institute of Virology Vaccines and Sera Torlak Immunology Research Center Branislav Jankovi   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84883810683     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-7091-0888-8_8     Document Type: Chapter

References (146)

1. Abe M, Watanabe N, Mc Donell N, Takato T, Ohira M, Nakagawara A, Ushijima T (2008) Identification of genes targeted by CpG island methylator phenotype in neuroblastomas, and their possible integrative involvement in poor prognosis. Oncology 74:50-60
2. Aguirre-Ghiso JA, Estrada Y, Liu D, Ossowski L (2003) ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK). Cancer Res 63:1684-1695
3. Ahmed AA, Mutt V, Nordlind K (1999) Modulating effects of sensory and autonomic neuropeptides on murine splenocyte proliferation and cytokine secretion induced by Leish-mania major. Immunopharmacol Immunotoxicol 21:507-526
4. Ahmed AA, Wahbi AH, Nordlin K (2001) Neuropeptides modulate a murine monocyte/macrophage cell line capacity for phagocytosis and killing of Leishmania major parasites. Immunopharmacol Immunotoxicol 23:397-409
5. Amlal H, Faroqui S, Balasubramaniam A, Sheriff S (2006) Estrogen up-regulates neuropeptide Y Y1 receptor expression in a human breast cancer cell line. Cancer Res 66:3706-3714
6. Barnum CJ, Blandino P Jr, Deak T (2007) Adaptation in the corticosterone and hyperthermic responses to stress following repeated stressor exposure. J Neuroendocrinol 19:632-642
7. Beck B, Burlet A, Bazin R, Nicolas JP, Burlet C (1993) Elevated neuropeptide Y in the arcuate nucleus of young obese Zucker rats may contribute to the development of their overeating. JNutr 123:1168-1172
8. Bedoui S, Kuhlmann S, Nave H, Drube J, Pabst R, von Horsten S (2001) Differential effects of neuropeptide Y (NPY) on leukocyte subsets in the blood: mobilization of B-1-like B-lymphocytes and activated monocytes. J Neuroimmunol 117:125-132
9. Bedoui S, Lechner S, Gebhardt T, Nave H, Beck-Sickinger AG, Straub RH, Pabst R, von Horsten S (2002) NPY modulates epinephrine-induced leukocytosis via Y-1 and Y-5 receptor activation in vivo: sympathetic co-transmission during leukocyte mobilization. J Neuroimmunol 132:25-33
10. Bedoui S, Miyake S, Lin Y, Miyamoto K, Oki S, Kawamura N, Beck-Sickinger A, von Horsten S, Yamamura T (2003) Neuropeptide Y (NPY) suppresses experimental autoimmune encephalomyelitis: NPY1 receptor-specific inhibition of autoreactive Th1 responses in vivo. J Immunol 171:3451-3458
11. Bedoui S, von Horsten S, Gebhardt T (2007) A role for neuropeptide Y (NPY) in phagocytosis: implications for innate and adaptive immunity. Peptides 28:373-376
12. Bedoui S, Kromer A, Gebhardt T, Jacobs R, Raber K, DimitrijeviC M, Heine J, von Horsten S (2008) Neuropeptide Y receptor-specifically modulates human neutrophil function. J Neuroimmunol 195:88-95
13. Berglund MM, Hipskind PA, Gehlert DR (2003) Recent developments in our understanding of the physiological role of PP-fold peptide receptor subtypes. Exp Biol Med (Maywood) 228:217-244
14. Bracci-Laudiero L, Aloe L, Stenfors C, Tirassa P, Theodorsson E, Lundberg T (1996a) Nerve growth factor stimulates production of neuropeptide Y in human lymphocytes. Neuroreport 7:485-488
15. Bracci-Laudiero L, Lundeberg T, Stenfors C, Theodorsson E, Tirassa P, Aloe L (1996b) Modification of lymphoid and brain nerve growth factor levels in systemic lupus erythematosus mice. Neurosci Lett 204:13-16
16. Bracci-Laudiero L, Aloe L, Stenfors C, Theodorsson E, Lundeberg T (1998) Development of systemic lupus erythematosus in mice is associated with alteration of neuropeptide concentrations in inflamed kidneys and immunoregulatory organs. Neurosci Lett 248:97-100
17. Broqua P, Wettstein JG, Rocher MN, Gauthier-Martin B, Riviere PJ, Junien JL, Dahl SG (1996) Antinociceptive effects of neuropeptide Y and related peptides in mice. Brain Res 724:25-32
18. Cabrele C, Beck-Sickinger AG (2000) Molecular characterization of the ligand-receptor interaction of the neuropeptide Y family. J Pept Sci 6:97-122
19. Castagne V, Corder R, Gaillard R, Mormede P (1987) Stress-induced changes of circulating neuropeptide Y in the rat: comparison with catecholamines. Regul Pept 19:55-63
20. Cooper HS, Murthy SN, Shah RS, Sedergran DJ (1993) Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 69:238-249
21. De la Fuente M, Bernaez I, Del Rio M, Hernanz A (1993) Stimulation of murine peritoneal macrophage functions by neuropeptide Y and peptide YY. Involvement of protein kinase C. Immunology 80:259-265
22. De la Fuente M, Medina S, Del Rio M, Ferrandez MD, Hernanz A (2000) Effect of aging on the modulation of macrophage functions by neuropeptides. Life Sci 67:2125-2135
23. De la Fuente M, Del Rio M, Medina S (2001a) Changes with aging in the modulation by neuropeptide Y of murine peritoneal macrophage functions. J Neuroimmunol 116:156-167
24. De la Fuente M, Del Rio M, Victor VM, Medina S (2001b) Neuropeptide Y effects on murine natural killer activity: changes with ageing and cAMP involvement. Regul Pept 101:73-79
25. Dimitrijevic M, Stanojevic S, Vujic V, Kovacevic-Jovanovic V, Beck-Sickinger A, Demuth H, von Horsten S (2002) Effect of neuropeptide Y on inflammatory paw edema in the rat: involvement of peripheral NPY Y1 and Y5 receptors and interaction with dipeptidyl-peptidase IV (CD26). J Neuroimmunol 129:35-42
26. Dimitrijevic M, Stanojevic: S, Vujic V, Beck-Sickinger A, von Horsten S (2005) Neuropeptide Y and its receptor subtypes specifically modulate rat peritoneal macrophage functions in vitro: counter regulation through Y1 and Y2/5 receptors. Regul Pept 124:163-172
27. Dimitrijevic M, Stanojevic S, Micic S, Vujic V, Kovacevic-Jovanovic V, Mitic K, von Horsten S, Kosec D (2006) Neuropeptide Y (NPY) modulates oxidative burst and nitric oxide production in carrageenan-elicited granulocytes from rat air pouch. Peptides 27:3208-3215
28. Dimitrijevic M, Stanojevic S, Mitic K, KustrimovicN, Vujic: V, Miletic T, Kovacevic-Jovanovic V (2008) The anti-inflammatory effect of neuropeptide Y (NPY) in rats is dependent on dipeptidyl peptidase 4 (DP4) activity and age. Peptides 29:2179-2187
29. Dimitrijevic M, Stanojevic S, Mitic K, Kustrimovic N, Vujic V, Miletic T, Kovacevic-Jovanovic V (2010) Modulation of granulocyte functions by peptide YY in the rat: age-related differences in Y receptors expression and plasma dipeptidyl peptidase 4 activity. Regul Pept 159:100-109
30. Du M, Butchi NB, Woods T, Morgan TW, Peterson KE (2010) Neuropeptide Y has a protective role during murine retrovirus induced neurological disease. J Virol 84:11076-11088
31. Elitsur Y, Luk GD, Colberg M, Gesell MS, Dosescu J, Moshier JA (1994) Neuropeptide Y (NPY) enhances proliferation of human colonic lamina propria lymphocytes. Neuropeptides 26:289-295
32. Ericsson A, Larhammar D, Mc Intyre KR, Persson H (1987) A molecular genetic approach to the identification of genes expressed predominantly in the neuroendocrine and immune systems. Immunol Rev 100:261-277
33. Frerker N, Wagner L, Wolf R, Heiser U, Hoffmann T, Rahfeld JU, Schade J, Karl T, Naim HY, Alfalah M, Demuth HU, von Horsten S (2007) Neuropeptide Y (NPY) cleaving enzymes: structural and functional homologues of dipeptidyl peptidase 4. Peptides 28:257-268
34. Fried G, Lundberg JM, Theodorsson-Norheim E (1985) Subcellular storage and axonal transport of neuropeptide Y (NPY) in relation to catecholamines in the cat. Acta Physiol Scand 125:145-154
35. Fuhlendorff J, Johansen NL, Melberg SG, Thogersen H, Schwartz TW (1990) The antiparallel pancreatic polypeptide fold in the binding of neuropeptide Y to Y1 and Y2 receptors. J Biol Chem 265:11706-11712
36. Gehlert DR (1998) Multiple receptors for the pancreatic polypeptide (PP-fold) family: physiological implications. Proc Soc Exp Biol Med 218:7-22
37. Ghersi G, Chen W, Lee EW, Zukowska Z (2001) Critical role of dipeptidyl peptidase IV in neuropeptide Y-mediated endothelial cell migration in response to wounding. Peptides 22:453-458
38. Gicquiaux H, Lecat S, Gaire M, Dieterlen A, Mely Y, Takeda K, Bucher B, Galzi JL (2002) Rapid internalization and recycling of the human neuropeptide Y Y(1) receptor. J Biol Chem 277:6645-6655
39. Gorrell MD (2005) Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders. Clin Sci (Lond) 108:277-292
40. Goumain M, Voisin T, Lorinet AM, Ducroc R, Tsocas A, Roze C, Rouet-Benzineb P, Herzog H, Balasubramaniam A, Laburthe M (2001) The peptide YY-preferring receptor mediating inhibition of small intestinal secretion is a peripheral Y(2) receptor: pharmacological evidence and molecular cloning. Mol Pharmacol 60:124-134
41. Grise KR, Rongione AJ, Laird EC, Mc Fadden DW (1999) Peptide YY inhibits growth of human breast cancer in vitro and in vivo. J Surg Res 82:151-155
42. Groneberg DA, Folkerts G, Peiser C, Chung KF, Fischer A (2004) Neuropeptide Y (NPY). Pulm Pharmacol Ther 17:173-180
43. Grouzmann E, Comoy E, Bohuon C (1989) Plasma neuropeptide Y concentrations in patients with neuroendocrine tumors. J Clin Endocrinol Metab 68:808-813
44. Grouzmann E, Fathi M, Gillet M, de Torrente A, Cavadas C, Brunner H, Buclin T (2001) Disappearance rate of catecholamines, total metanephrines, and neuropeptide Y from the plasma of patients after resection of pheochromocytoma. Clin Chem 47:1075-1082
45. Han S, Yang CL, Chen X, Naes L, Cox BF, Westfall T (1998) Direct evidence for the role of neuropeptide Y in sympathetic nerve stimulation-induced vasoconstriction. Am J Physiol 274: H290-H294
46. Hansel DE, Eipper BA, Ronnett GV (2001) Neuropeptide Y functions as a neuroproliferative factor. Nature 410:940-944
47. Harle P, Straub RH, Wiest R, Mayer A, Scholmerich J, Atzeni F, Carrabba M, Cutolo M, Sarzi-Puttini P (2006) Increase of sympathetic outflow measured by neuropeptide Y and decrease of the hypothalamic-pituitary-adrenal axis tone in patients with systemic lupus erythematosus and rheumatoid arthritis: another example of uncoupling of response systems. Ann Rheum Dis 65:51-56
48. Hassani H, Lucas G, Rozell B, Ernfors P (2005) Attenuation of acute experimental colitis by preventing NPY Y1 receptor signaling. Am J Physiol Gastrointest Liver Physiol 288: G550-G556
49. Heilig M (1995) Antisense inhibition of neuropeptide Y (NPY)-Y1 receptor expression blocks the anxiolytic-like action of NPY in amygdala and paradoxically increases feeding. Regul Pept 59:201-205
50. Hernanz A, Tato E, De la Fuente M, de Miguel E, Arnalich F (1996) Differential effects of gastrin-releasing peptide, neuropeptide Y, somatostatin and vasoactive intestinal peptide on interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha production by whole blood cells from healthy young and old subjects. J Neuroimmunol 71:25-30
51. Herzog H, Hort YJ, Ball HJ, Hayes G, Shine J, Selbie LA (1992) Cloned human neuropeptide Y receptor couples to two different second messenger systems. Proc Natl Acad Sci USA 89:5794-5798
52. Hirai H, Miura J, Hu Y, Larsson H, Larsson K, Lernmark A, Ivarsson SA, Wu T, Kingman A, Tzioufas AG, Notkins AL (2008) Selective screening of secretory vesicle-associated proteins for autoantigens in type 1 diabetes: VAMP2 and NPY are new minor autoantigens. Clin Immunol 127:366-374
53. Holler J, Zakrzewicz A, Kaufmann A, Wilhelm J, Fuchs-Moll G, Dietrich H, Padberg W, Kuncova J, Kummer W, Grau V (2008) Neuropeptide Y is expressed by rat mononuclear blood leukocytes and strongly down-regulated during inflammation. J Immunol 181:6906-6912
54. Hristova M, Aloe L (2006) Metabolic syndrome-neurotrophic hypothesis. Med Hypotheses 66:545-549
55. Irwin M, Hauger R, Brown M (1992) Central corticotropin-releasing hormone activates the sympathetic nervous system and reduces immune function: increased responsivity of the aged rat. Endocrinology 131:1047-1053
56. Jacob HJ, Pettersson A, Wilson D, Mao Y, Lernmark A, Lander ES (1992) Genetic dissection of autoimmune type I diabetes in the BB rat. Nat Genet 2:56-60
57. Kawamura N, Tamura H, Obana S, Wenner M, Ishikawa T, Nakata A, Yamamoto H (1998) Differential effects of neuropeptides on cytokine production by mouse helper T cell subsets. Neuroimmunomodulation 5:9-15
58. Kim YW, Kim KH, Ahn DK, Kim HS, Kim JY, Lee DC, Park SY (2007) Time-course changes of hormones and cytokines by lipopolysaccharide and its relation with anorexia. J Physiol Sci 57:159-165
59. Kitlinska J, Abe K, Kuo L, Pons J, Yu M, Li L, Tilan J, Everhart L, Lee EW, Zukowska Z, Toretsky JA (2005) Differential effects of neuropeptide Y on the growth and vascularization of neural crest-derived tumors. Cancer Res 65:1719-1728
60. Kogner P, Ericsson A, Barbany G, Persson H, Theodorsson E, Bjork O (1992) Neuropeptide Y (NPY) synthesis in lymphoblasts and increased plasma NPY in pediatric B-cell precursor leukemia. Blood 80:1324-1329
61. Kopp J, Nanobashvili A, Kokaia Z, Lindvall O, Hokfelt T (1999) Differential regulation of mRNAs for neuropeptide Y and its receptor subtypes in widespread areas of the rat limbic system during kindling epileptogenesis. Brain Res Mol Brain Res 72:17-29
62. Korner M, Waser B, Reubi JC (2004) High expression of neuropeptide y receptors in tumors of the human adrenal gland and extra-adrenal paraganglia. Clin Cancer Res 10:8426-8433
63. Korner M, Waser B, Reubi JC (2005) Neuropeptide Y receptors in renal cell carcinomas and nephroblastomas. Int J Cancer 115:734-741
64. Korner M, Waser B, Reubi JC (2008) High expression of neuropeptide Y1 receptors in ewing sarcoma tumors. Clin Cancer Res 14:5043-5049
65. Lacroix JS, Mosimann BL (1996) Attenuation of allergen-evoked nasal responses by local pretreatment with exogenous neuropeptide Y in atopic patients. J Allergy Clin Immunol 98:611-616
66. Lacroix JS, Ricchetti AP, Morel D, Mossimann B, Waeber B, Grouzmann E (1996) Intranasal administration of neuropeptide Y in man: systemic absorption and functional effects. Br J Pharmacol 118:2079-2084
67. Lambert RW, Campton K, Ding W, Ozawa H, Granstein RD (2002) Langerhans cell expression of neuropeptide Y and peptide YY. Neuropeptides 36:246-251
68. Langer M, La Bella R, Garcia-Garayoa E, Beck-Sickinger AG (2001) 99mTc-labeled neuropeptide Y analogues as potential tumor imaging agents. Bioconjug Chem 12:1028-1034
69. Larhammar D (1996) Evolution of neuropeptide Y, peptide YY and pancreatic polypeptide. Regul Pept 62:1-11
70. Larhammar D, Wraith A, Berglund MM, Holmberg SK, Lundell I (2001) Origins of the many NPY-family receptors in mammals. Peptides 22:295-307
71. Levite M (1998) Neuropeptides, by direct interaction with T cells, induce cytokine secretion and break the commitment to a distinct T helper phenotype. Proc Natl Acad Sci USA 95: 12544-12549
72. Levite M (2000) Nerve-driven immunity. The direct effects of neurotransmitters on T-cell function. Ann N Y Acad Sci 917:307-321
73. Levite M, Cahalon L, Hershkoviz R, Steinman L, Lider O (1998) Neuropeptides, via specific receptors, regulate T cell adhesion to fibronectin. J Immunol 160:993-1000
74. Liu CD, Balasubramaniam A, Saxton RE, Paiva M, Mc Fadden DW (1995) Human pancreatic cancer growth is inhibited by peptide YY and BIM-43004-1. J Surg Res 58:707-712
75. Liu J, Li J, Zhai N, Geng L, Song F (2004) Detection of the levels of neuropeptides, ACTH and cortisol in the blood of patients with polymyositis/dermatomyositis and their significance. J Dermatol 31:392-397
76. Lu C, Everhart L, Tilan J, Kuo L, Sun CC, Munivenkatappa RB, Jonsson-Rylander AC, Sun J, Kuan-Celarier A, Li L, Abe K, Zukowska Z, Toretsky JA, Kitlinska J (2010) Neuropeptide Y and its Y2 receptor: potential targets in neuroblastoma therapy. Oncogene 29:5630-5642
77. Lundberg JM, Terenius L, Hokfelt T, Goldstein M (1983) High levels of neuropeptide Y in peripheral noradrenergic neurons in various mammals including man. Neurosci Lett 42: 167-172
78. Lundberg JM, Saria A, Franco-Cereceda A, Hokfelt T, Terenius L, Goldstein M (1985) Differential effects of reserpine and 6-hydroxydopamine on neuropeptide Y (NPY) and noradrenaline in peripheral neurons. Naunyn Schmiedebergs Arch Pharmacol 328:331-340
79. Maeda K, Yasuda M, Kaneda H, Maeda S, Yamadori A (1994) Cerebrospinal fluid (CSF) neuropeptide Y-and somatostatin-like immunoreactivities in man. Neuropeptides 27:323-332
80. Malmstrom RE (1997) Neuropeptide Y Y1 receptor mechanisms in sympathetic vascular control.Acta Physiol Scand Suppl 636:1-55
81. Marsh DJ, Baraban SC, Hollopeter G, Palmiter RD (1999) Role of the Y5 neuropeptide Y receptor in limbic seizures. Proc Natl Acad Sci USA 96:13518-13523
82. Mc Laughlin CL, Tou JS, Rogan GJ, Baile CA (1991) Full amino acid sequence of centrally administered NPY required for maximal food intake response. Physiol Behav 49:521-526
83. Medina S, Del Rio M, Manuel Victor V, Hernanz A, De la Fuente M (1998) Changes with ageing in the modulation of murine lymphocyte chemotaxis by CCK-8 S, GRP and NPY. Mech Ageing Dev 102:249-261
84. Medina S, Rio MD, Cuadra BD, Guayerbas N, Fuente MD (1999) Age-related changes in the modulatory action of gastrin-releasing peptide, neuropeptide Y and sulfated cholecystokinin octapeptide in the proliferation of murine lymphocytes. Neuropeptides 33:173-179
85. Medina S, Del Rio M, Hernanz A, De la Fuente M (2000a) Age-related changes in the neuropeptide Y effects on murine lymphoproliferation and interleukin-2 production. Peptides 21:1403-1409
86. Medina S, Del Rio M, Hernanz A, De la Fuente M (2000b) The NPY effects on murine leukocyte adherence and chemotaxis change with age. Adherent cell implication. Regul Pept 95:35-45
87. Meltzer JC, Grimm PC, Greenberg AH, Nance DM (1997) Enhanced immunohistochemical detection of autonomic nerve fibers, cytokines and inducible nitric oxide synthase by light and fluorescent microscopy in rat spleen. J Histochem Cytochem 45:599-610
88. Mentlein R (1999) Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides. Regul Pept 85:9-24
89. Mentlein R, Roos T (1996) Proteases involved in the metabolism of angiotensin II, bradykinin, calcitonin gene-related peptide (CGRP), and neuropeptide Y by vascular smooth muscle cells. Peptides 17:709-720
90. Michel MC, Beck-Sickinger A, Cox H, Doods HN, Herzog H, Larhammar D, Quirion R, Schwartz T, Westfall T (1998) XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol Rev 50:143-150
91. Morimoto C, Schlossman SF (1998) The structure and function of CD26 in the T-cell immune response. Immunol Rev 161:55-70
92. Muller S, Weihe E (1991) Interrelation of peptidergic innervation with mast cells and ED1-positive cells in rat thymus. Brain Behav Immun 5:55-72
93. Mullins DE, Zhang X, Hawes BE (2002) Activation of extracellular signal regulated protein kinase by neuropeptide Y and pancreatic polypeptide in CHO cells expressing the NPY Y(1), Y(2), Y(4) and Y(5) receptor subtypes. Regul Pept 105:65-73
94. Myers AK, Farhat MY, Vaz CA, Keiser HR, Zukowska-Grojec Z (1988) Release of immunoreac-tive-neuropeptide by rat platelets. Biochem Biophys Res Commun 155:118-122
95. Nair MP, Schwartz SA, Wu K, Kronfol Z (1993) Effect of neuropeptide Y on natural killer activity of normal human lymphocytes. Brain Behav Immun 7:70-78
96. Nave H, Bedoui S, MoenterF, Steffens J, Felies M, Gebhardt T, Straub RH, PabstR, Dimitrijevic M, Stanojevic S, von Horsten S (2004) Reduced tissue immigration of monocytes by neuropeptide Y during endotoxemia is associated with Y2 receptor activation. J Neuroimmunol 155:1-12
97. Niskanen L, Karvonen MK, Valve R, Koulu M, Pesonen U, Mercuri M, Rauramaa R, Toyry J, Laakso M, Uusitupa MI (2000) Leucine 7 to proline 7 polymorphism in the neuropeptide Y gene is associated with enhanced carotid atherosclerosis in elderly patients with type 2 diabetes and control subjects. J Clin Endocrinol Metab 85:2266-2269
98. Nohr D, Weihe E (1991) The neuroimmune link in the bronchus-associated lymphoid tissue (BALT) of cat and rat: peptides and neural markers. Brain Behav Immun 5:84-101 Pang XH, Li TK, Xie Q, He FQ, de Cui J, Chen YQ, Huang XL, Gan HT (2010) Amelioration of dextran sulfate sodium-induced colitis by neuropeptide Y antisense oligodeoxynucleotide. Int J Colorectal Dis 25:1047-1053
99. Pedrazzini T, Pralong F, Grouzmann E (2003) Neuropeptide Y: the universal soldier. Cell Mol Life Sci 60:350-377
100. Pereira da Silva JA, Carmo-Fonseca M (1990) Peptide containing nerves in human synovium: immunohistochemical evidence for decreased innervation in rheumatoid arthritis. J Rheumatol 17:1592-1599
101. Peters A (2010) Incretin-based therapies: review of current clinical trial data. Am J Med 123: S28-S37
102. Petitto JM, Huang Z, Mc Carthy DB (1994) Molecular cloning of NPY-Y1 receptor cDNA from rat splenic lymphocytes: evidence of low levels of mRNA expression and [125I]NPY binding sites. J Neuroimmunol 54:81-86
103. Puerto M, Guayerbas N, Alvarez P, De la Fuente M (2005) Modulation of neuropeptide Y and norepinephrine on several leucocyte functions in adult, old and very old mice. J Neuroimmunol 165:33-40
104. Rasiah KK, Kench JG, Gardiner-Garden M, Biankin AV, Golovsky D, Brenner PC, Kooner R, O’Neill GF, Turner JJ, Delprado W, Lee CS, Brown DA, Breit SN, Grygiel JJ, Horvath LG, Stricker PD, Sutherland RL, Henshall SM (2006) Aberrant neuropeptide Y and macrophage inhibitory cytokine-1 expression are early events in prostate cancer development and are associated with poor prognosis. Cancer Epidemiol Biomarkers Prev 15:711-716
105. Reich A, Orda A, Wisnicka B, Szepietowski JC (2007) Plasma concentration of selected neuropeptides in patients suffering from psoriasis. Exp Dermatol 16:421-428
106. Reinhold D, Kahne T, Steinbrecher A, Wrenger S, Neubert K, Ansorge S, Brocke S (2002) The role of dipeptidyl peptidase IV (DP IV) enzymatic activity in T cell activation and autoimmunity. Biol Chem 383:1133-1138
107. Rethnam S, Raju B, Fristad I, Berggreen E, Heyeraas KJ (2010) Differential expression of neuropeptide Y Y1 receptors during pulpal inflammation. Int Endod J 43:492-498
108. Romano TA, Felten SY, Felten DL, Olschowka JA (1991) Neuropeptide-Y innervation of the rat spleen: another potential immunomodulatory neuropeptide. Brain Behav Immun 5:116-131
109. Sainsbury A, Schwarzer C, Couzens M, Fetissov S, Furtinger S, Jenkins A, Cox HM, Sperk G, Hokfelt T, Herzog H (2002) Important role of hypothalamic Y2 receptors in body weight regulation revealed in conditional knockout mice. Proc Natl Acad Sci USA 99:8938-8943
110. Sajdyk TJ, Schober DA, Gehlert DR (2002) Neuropeptide Y receptor subtypes in the basolateral nucleus of the amygdala modulate anxiogenic responses in rats. Neuropharmacology 43:1165-1172
111. Salomon J, Baran E (2008) The role of selected neuropeptides in pathogenesis of atopic dermatitis.J Eur Acad Dermatol Venereol 22:223-228
112. Saurer TB, Ijames SG, Lysle DT (2006) Neuropeptide Y Y1 receptors mediate morphine-induced reductions of natural killer cell activity. J Neuroimmunol 177:18-26
113. Sawa T, Mameya S, Yoshimura M, Itsuno M, Makiyama K, Niwa M, Taniyama K (1995) Differential mechanism of peptide YY and neuropeptide Y in inhibiting motility of guinea-pig colon. Eur J Pharmacol 276:223-230
114. Schally AV, Nagy A (1999) Cancer chemotherapy based on targeting of cytotoxic peptide conjugates to their receptors on tumors. Eur J Endocrinol 141:1-14
115. Schneider JE (2004) Energy balance and reproduction. Physiol Behav 81:289-317
116. Schroeder JP, Olive F, Koenig H, Hodge CW (2003) Intra-amygdala infusion of the NPY Y1 receptor antagonist BIBP 3226 attenuates operant ethanol self-administration. Alcohol Clin Exp Res 27:1884-1891
117. Schwarz H, Villiger PM, von Kempis J, Lotz M (1994) Neuropeptide Y is an inducible gene in the human immune system. J Neuroimmunol 51:53-61
118. Sheriff S, Ali M, Yahya A, Haider KH, Balasubramaniam A, Amlal H (2010) Neuropeptide Y Y5 receptor promotes cell growth through extracellular signal-regulated kinase signaling and cyclic AMP inhibition in a human breast cancer cell line. Mol Cancer Res 8:604-614
119. Shibata M, Hisajima T, Nakano M, Goris RC, Funakoshi K (2008) Morphological relationships between peptidergic nerve fibers and immunoglobulin A-producing lymphocytes in the mouse intestine. Brain Behav Immun 22:158-166
120. Shin SH, Kim BH, Jang JJ, Suh KS, Kang GH (2010) Identification of novel methylation markers in hepatocellular carcinoma using a methylation array. J Korean Med Sci 25:1152-1159
121. Sindelar DK, Ste Marie L, Miura GI, Palmiter RD, Mc Minn JE, Morton GJ, Schwartz MW (2004) Neuropeptide Y is required for hyperphagic feeding in response to neuroglucopenia. Endocrinology 145:3363-3368
122. Sipos G, Altdorfer K, Pongor E, Chen LP, Feher E (2006) Neuroimmune link in the mucosa of chronic gastritis with Helicobacter pylori infection. Dig Dis Sci 51:1810-1817
123. Skibola DR, Smith MT, Bracci PM, Hubbard AE, Agana L, Chi S, Holly EA (2005) Polymorphisms in ghrelin and neuropeptide Y genes are associated with non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 14:1251-1256
124. Soder O, Hellstrom PM (1987) Neuropeptide regulation of human thymocyte, guinea pig T lymphocyte and rat B lymphocyte mitogenesis. Int Arch Allergy Appl Immunol 84:205-211
125. Souli A, Chariot J, Voisin T, Presset O, Tsocas A, Balasubramaniam A, Laburthe M, Roze C (1997) Several receptors mediate the antisecretory effect of peptide YY, neuropeptide Y, and pancreatic polypeptide on VIP-induced fluid secretion in the rat jejunum in vivo. Peptides 18:551-557
126. Stanojevic S, Vujic V, Kovacevic-Jovanovic V, Mitic K, Kosec D, Horsten S, Dimitrijevic M (2006) Age-related effect of peptide YY (PYY) on paw edema in the rat: the function of Y1 receptors on inflammatory cells. Exp Gerontol 41:793-799
127. Stanojevic S, Mitic: K, Vujic: V, Kovacevic-Jovanovic V, Dimitrijevic M (2007) Exposure to acute physical and psychological stress alters the response of rat macrophages to corticosterone, neuropeptide Y and beta-endorphin. Stress 10:65-73
128. 2) release by rat peritoneal macrophages involves different types of opioid receptors. Neuropeptides 42:147-158
129. Steinbrecher A, Reinhold D, Quigley L, Gado A, Tresser N, Izikson L, Born I, Faust J, Neubert K, Martin R, Ansorge S, Brocke S (2001) Targeting dipeptidyl peptidase IV (CD26) suppresses autoimmune encephalomyelitis and up-regulates TGF-beta 1 secretion in vivo. J Immunol 166:2041-2048
130. Straub RH, Mayer M, Kreutz M, Leeb S, Scholmerich J, Falk W (2000) Neurotransmitters of the sympathetic nerve terminal are powerful chemoattractants for monocytes. J Leukoc Biol 67:553-558
131. Taherzadeh S, Sharma S, Chhajlani V, Gantz I, Rajora N, Demitri MT, Kelly L, Zhao H, Ichiyama T, Catania A, Lipton JM (1999) a-MSH and its receptors in regulation of tumor necrosis factor-a production by human monocyte/macrophages. Am J Physiol Regul Integr Comp Physiol 276: R1289-R1294
132. Talme T, Liu Z, Sundqvist KG (2008) The neuropeptide calcitonin gene-related peptide (CGRP) stimulates T cell migration into collagen matrices. J Neuroimmunol 196:60-66
133. Tatemoto K, Carlquist M, Mutt V (1982) Neuropeptide Y-a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 296:659-660
134. Thompson AC, Justice JB Jr, Mc Donald JK (1995) Quantitative microdialysis of neuropeptide Y.J Neurosci Methods 60:189-198
135. Tilan J, Kitlinska J (2010) Sympathetic neurotransmitters and tumor angiogenesis-link between stress and cancer progression. J Oncol. doi:10.1155/2010/539706
136. Vouldoukis I, Shai Y, Nicolas P, Mor A (1996) Broad spectrum antibiotic activity of the skin-PYY. FEBS Lett 380:237-240
137. Vujic V, Stanojevic: S, Dimitrijevic M (2004) Methionine-enkephalin stimulates hydrogen peroxide and nitric oxide production in rat peritoneal macrophages: interaction of mu, delta and kappa opioid receptors. Neuroimmunomodulation 11:392-403
138. Wahlestedt C, Edvinsson L, Ekblad E, Hakanson R (1985) Neuropeptide Y potentiates noradrenaline-evoked vasoconstriction: mode of action. J Pharmacol Exp Ther 234:735-741
139. Weinstock JV, Elliott D (1998) The substance P and somatostatin interferon-gamma immunoreg-ulatory circuit. Ann N Y Acad Sci 840:532-539
140. Wheway J, Mackay CR, Newton RA, Sainsbury A, Boey D, Herzog H, Mackay F (2005) A fundamental bimodal role for neuropeptide Y1 receptor in the immune system. J Exp Med 202:1527-1538
141. Wheway J, Herzog H, Mackay F (2007) The Y1 receptor for NPY: a key modulator of the adaptive immune system. Peptides 28:453-458
142. Yu A, Somasundar P, Balsubramaniam A, Rose AT, Vona-Davis L, Mc Fadden DW (2002) Vitamin E and the Y4 agonist BA-129 decrease prostate cancer growth and production of vascular endothelial growth factor. J Surg Res 105:65-68
143. Zhou JR, Xu Z, Jiang CL (2008) Neuropeptide Y promotes TGF-beta1 production in RAW264.7 cells by activating PI3K pathway via Y1 receptor. Neurosci Bull 24:155-159
144. Zukowska-Grojec Z, Vaz AC (1988) Role of neuropeptide Y (NPY) in cardiovascular responses to stress. Synapse 2:293-298
145. Zukowska-Grojec Z, Karwatowska-Prokopczuk E, Rose W, Rone J, Movafagh S, Ji H, Yeh Y, Chen WT, Kleinman HK, Grouzmann E, Grant DS (1998) Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium. Circ Res 83:187-195
146. Zwanziger D, Khan IU, Neundorf I, Sieger S, Lehmann L, Friebe M, Dinkelborg L, Beck-Sickinger AG (2008) Novel chemically modified analogues of neuropeptide Y for tumor targeting. Bioconjug Chem 19:1430-1438